Carrier EJ - Search Results

1

The postmortal accumulation of brain N-arachidonylethanolamine (anandamide) is dependent upon fatty acid amide hydrolase activity.

Patel S, Carrier EJ, Ho WS, Rademacher DJ, Cunningham S, Reddy DS, Falck JR, Cravatt BF, Hillard CJ. Patel S, et al. Among authors: carrier ej. J Lipid Res. 2005 Feb;46(2):342-9. doi: 10.1194/jlr.M400377-JLR200. Epub 2004 Dec 1. J Lipid Res. 2005. PMID: 15576840 Free article.

2

The general anesthetic propofol increases brain N-arachidonylethanolamine (anandamide) content and inhibits fatty acid amide hydrolase.

Patel S, Wohlfeil ER, Rademacher DJ, Carrier EJ, Perry LJ, Kundu A, Falck JR, Nithipatikom K, Campbell WB, Hillard CJ. Patel S, et al. Among authors: carrier ej. Br J Pharmacol. 2003 Jul;139(5):1005-13. doi: 10.1038/sj.bjp.0705334. Br J Pharmacol. 2003. PMID: 12839875 Free PMC article.

3

Endocannabinoids in neuroimmunology and stress.

Carrier EJ, Patel S, Hillard CJ. Carrier EJ, et al. Curr Drug Targets CNS Neurol Disord. 2005 Dec;4(6):657-65. doi: 10.2174/156800705774933023. Curr Drug Targets CNS Neurol Disord. 2005. PMID: 16375683 Review.

4

Production of hydroxyeicosatetraenoic acids and prostaglandins by a novel rat microglial cell line.

Rademacher DJ, Kearn CS, Carrier EJ, Patel S, Delgado MA, Barkmeier A, Klick DE, Breese NM, Pfister SL, Nithipatikom K, Campbell WB, Hillard CJ. Rademacher DJ, et al. Among authors: carrier ej. J Neuroimmunol. 2004 Apr;149(1-2):130-41. doi: 10.1016/j.jneuroim.2003.12.022. J Neuroimmunol. 2004. PMID: 15020073

5

Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression.

Carrier EJ, Auchampach JA, Hillard CJ. Carrier EJ, et al. Proc Natl Acad Sci U S A. 2006 May 16;103(20):7895-900. doi: 10.1073/pnas.0511232103. Epub 2006 May 3. Proc Natl Acad Sci U S A. 2006. PMID: 16672367 Free PMC article.

6

Electroconvulsive shock treatment differentially modulates cortical and subcortical endocannabinoid activity.

Hill MN, Barr AM, Ho WS, Carrier EJ, Gorzalka BB, Hillard CJ. Hill MN, et al. Among authors: carrier ej. J Neurochem. 2007 Oct;103(1):47-56. doi: 10.1111/j.1471-4159.2007.04688.x. Epub 2007 Jun 11. J Neurochem. 2007. PMID: 17561935 Free article.

7

Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli.

Maresz K, Carrier EJ, Ponomarev ED, Hillard CJ, Dittel BN. Maresz K, et al. Among authors: carrier ej. J Neurochem. 2005 Oct;95(2):437-45. doi: 10.1111/j.1471-4159.2005.03380.x. Epub 2005 Aug 8. J Neurochem. 2005. PMID: 16086683 Free article.

8

Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress.

Hill MN, Miller GE, Carrier EJ, Gorzalka BB, Hillard CJ. Hill MN, et al. Among authors: carrier ej. Psychoneuroendocrinology. 2009 Sep;34(8):1257-62. doi: 10.1016/j.psyneuen.2009.03.013. Epub 2009 Apr 25. Psychoneuroendocrinology. 2009. PMID: 19394765 Free PMC article.

9

Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism.

Carrier EJ, Kearn CS, Barkmeier AJ, Breese NM, Yang W, Nithipatikom K, Pfister SL, Campbell WB, Hillard CJ. Carrier EJ, et al. Mol Pharmacol. 2004 Apr;65(4):999-1007. doi: 10.1124/mol.65.4.999. Mol Pharmacol. 2004. PMID: 15044630

10

Prolonged glucocorticoid treatment decreases cannabinoid CB1 receptor density in the hippocampus.

Hill MN, Carrier EJ, Ho WS, Shi L, Patel S, Gorzalka BB, Hillard CJ. Hill MN, et al. Among authors: carrier ej. Hippocampus. 2008;18(2):221-6. doi: 10.1002/hipo.20386. Hippocampus. 2008. PMID: 18058925

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters